The GV and EMBL Ventures-backed immunotherapy developer floated in an underpriced offering and received $20m in a private placement from NEA.

BitAuto's e-commerce and financing spinout, which counts Tencent, Baidu and JD.com as investors, floated at the top of its range.

Bertelsmann and JD.com-backed LexinFintech, which runs lending and e-commerce marketplace Fenqile, will float in the US.

Pennsylvania spinout Apellis Pharmaceuticals has floated on the Nasdaq Global Select Market after raising $150m in its initial public offering.

Entera Bio, a large-molecule drug spinout of DNA Biomedical Solutions, intends to raise up to $50m when it goes public.

The China-based, SIG-backed online lender floated below its range in the US and is currently hovering just above the IPO price.

EMBL-backed Arsanis hopes to sell 3,125,000 shares priced at $15 to $17 and raise a total of up to $61m in its initial public offering.

The immunoassay instrument developer is targeting $57.5m in an offering that will provide exits for BioMerieux and Stratec Biomedical.

The Tencent and Sohu-backed search engine operator will go public in the US today, floating at the top of its range.